Waters Corporation (BMV:WAT)
Mexico · Delayed Price · Currency is MXN 5,342.00
0.00 (0.00%)
At close: Aug 8, 2025, 2:00 PM CST
Theseus Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 28, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 661.39 | 637.83 | 642.23 | 707.76 | 692.84 | 521.57 | Upgrade |
Depreciation & Amortization | 197.1 | 191.83 | 165.91 | 130.42 | 131.68 | 125.36 | Upgrade |
Asset Writedown & Restructuring Costs | - | - | - | 10 | - | 6.95 | Upgrade |
Loss (Gain) From Sale of Investments | - | - | -0.74 | - | -9.71 | - | Upgrade |
Stock-Based Compensation | 48.34 | 44.71 | 36.87 | 42.56 | 29.92 | 36.87 | Upgrade |
Other Operating Activities | -2.96 | -0.88 | -1.2 | -31.99 | 16.63 | -2.69 | Upgrade |
Change in Accounts Receivable | -93.01 | -66.24 | 49.18 | -137.87 | -62.45 | 37.47 | Upgrade |
Change in Inventory | 1.98 | 20.94 | -45.44 | -101.9 | -67.25 | 18.94 | Upgrade |
Change in Accounts Payable | -71.3 | 61.59 | -79.52 | 60.98 | 46.11 | 140.6 | Upgrade |
Change in Unearned Revenue | 1.24 | 6.17 | 10.43 | 12.86 | 37.85 | 11.07 | Upgrade |
Change in Other Net Operating Assets | 2.63 | -133.82 | -174.9 | -81.17 | -68.35 | -105.62 | Upgrade |
Operating Cash Flow | 745.41 | 762.12 | 602.81 | 611.66 | 747.27 | 790.51 | Upgrade |
Operating Cash Flow Growth | 5.68% | 26.43% | -1.45% | -18.15% | -5.47% | 22.92% | Upgrade |
Capital Expenditures | -126.06 | -142.48 | -160.63 | -175.92 | -161.27 | -172.38 | Upgrade |
Cash Acquisitions | -34.97 | - | -1,282 | - | - | -80.55 | Upgrade |
Sale (Purchase) of Intangibles | - | - | - | -7.54 | -7 | - | Upgrade |
Investment in Securities | -1.74 | -1.54 | 0.72 | 75.49 | -63.36 | -11.17 | Upgrade |
Investing Cash Flow | -162.76 | -144.02 | -1,442 | -107.97 | -231.63 | -264.09 | Upgrade |
Long-Term Debt Issued | - | 170 | 1,450 | 205 | 510 | 315 | Upgrade |
Long-Term Debt Repaid | - | -900 | -670.04 | -145 | -350 | -640.37 | Upgrade |
Net Debt Issued (Repaid) | -550 | -730 | 780 | 60 | 160 | -325.37 | Upgrade |
Issuance of Common Stock | 21.27 | 30.37 | 29.79 | 42.8 | 55.64 | 66.03 | Upgrade |
Repurchase of Common Stock | -14.52 | -13.54 | -70.28 | -626.06 | -648.93 | -196.41 | Upgrade |
Other Financing Activities | -1.49 | 16.5 | 15.44 | 13.63 | -4.99 | 15.24 | Upgrade |
Financing Cash Flow | -544.74 | -696.68 | 754.95 | -509.63 | -438.28 | -440.5 | Upgrade |
Foreign Exchange Rate Adjustments | 1.94 | 7.92 | -0.95 | -14.77 | -12.83 | 15.07 | Upgrade |
Net Cash Flow | 39.85 | -70.66 | -85.45 | -20.71 | 64.54 | 100.98 | Upgrade |
Free Cash Flow | 619.36 | 619.64 | 442.18 | 435.74 | 586.01 | 618.12 | Upgrade |
Free Cash Flow Growth | 10.41% | 40.13% | 1.48% | -25.64% | -5.20% | 28.97% | Upgrade |
Free Cash Flow Margin | 20.33% | 20.95% | 14.96% | 14.66% | 21.04% | 26.13% | Upgrade |
Free Cash Flow Per Share | 10.38 | 10.40 | 7.46 | 7.22 | 9.45 | 9.90 | Upgrade |
Cash Interest Paid | 92.1 | 92.1 | 94.1 | 48.08 | 42.41 | 52.1 | Upgrade |
Cash Income Tax Paid | 183.34 | 183.34 | 243.32 | 160.08 | 153.5 | 97.62 | Upgrade |
Levered Free Cash Flow | 465.32 | 627.06 | 455.51 | 345.17 | 405.57 | 547.89 | Upgrade |
Unlevered Free Cash Flow | 508.48 | 683.11 | 517.3 | 375.67 | 433.66 | 578.56 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.